OpenAI has launched GPT-Rosalind, an AI model tailored for life sciences, alongside new research from UC San Diego on a machine learning tool that more accurately predicts Type 1 diabetes risk. These ...
The United States Food and Drug Administration (FDA) issued guidance on its “Breakthrough Devices Program” in 2023.  The ...
ClearNote Health, a company dedicated to improving early detection for some of the deadliest cancers, today announced its ...
An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
This predictive model built on readily acquired clinical data provides encouraging results for the detection of residual disease. External validation and prospective studies implementing the model in ...
Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...
The dogs are detecting changes in volatile organic compounds — substances produced by the body when diseases like cancer are ...